Dr. Birendra Prasad Sah, MD

Dr. Sah practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Sah's NPI, 1417111287, was assigned on July 10, 2008. Dr. Sah graduated from B.P. Koirala Institute of Health Sciences in 2002. Dr. Sah holds New York license 269316.

Dr. Sah's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Sah's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Sah is also affiliated with Auburn Community Hospital. The medical group on file is Department of Medicine. Dmand AI also links Dr. Sah to 4 more medical groups, 3 group practices and clinics and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sah practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sah's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Sah is licensed in New York.

CMS data shows 449 Medicare services from Dr. Sah across 6 procedure codes in 2024, for 264 Medicare patients. Medicare paid $47,392 for them.

CMS counts 264 Medicare patients who saw Dr. Sah in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sah's median patient age at 64, with 51% women.

In 2024, Dr. Sah wrote 1,138 Medicare Part D claims for 158 patients. 53% of them were for generic drugs. CMS names the drug for 942 of them, across 27 drugs with 11 or more claims each, at $1,957,641 in total drug cost. In 2023, CMS named 1,152 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sah for performance year 2024, reported as part of a group. Dr. Sah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sah as offering telehealth.

Dmand AI links 22 papers to Dr. Sah, published from 2014 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Sarcoidosis, Double-Blind Method and Nepal. Dr. Sah has published most often in JNMA J Nepal Med Assoc. Dr. Sah's most frequent co-authors are Michael C. Iannuzzi, MD, Dipti Baral, MBBS and Rumon Chakravarty, MD.

Dmand AI links Dr. Sah to 1 clinical trial. Conditions studied include Hypotension and Vascular Diseases.

CMS Open Payments shows 61 general payments to Dr. Sah from 16 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 67% of the total. Merck Sharp & Dohme Corporation paid the most, $2,350.

Dr. Sah graduated from B.P. Koirala Institute of Health Sciences in 2002.